SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-23-009298 from INTENSITY THERAPEUTICS, INC. (INTS)

INTENSITY THERAPEUTICS, INC.
Date: Feb. 8, 2023 · CIK: 0001567264 · Accession: 0001213900-23-009298

AI Filing Summary & Sentiment

File numbers found in text: 333-260565

Date
February 8, 2023
Author
BENCHMARK COMPANY, LLC
Form
CORRESP
Company
INTENSITY THERAPEUTICS, INC.

Letter

Re: Intensity Therapeutics, Inc.

February 8, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1

File No. 333-260565

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on February 6, 2023, in which we, as representative of the several underwriters of Intensity Therapeutics, Inc.’s proposed public offering, joined Intensity Therapeutics, Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for February 8, 2023, at 4:30 p.m. Eastern Time. Intensity Therapeutics, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,
THE
BENCHMARK COMPANY, LLC

Show Raw Text
CORRESP
1
filename1.htm

February 8, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    Intensity Therapeutics, Inc.

    Registration Statement on Form S-1

    File No. 333-260565

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence
via EDGAR on February 6, 2023, in which we, as representative of the several underwriters of Intensity Therapeutics, Inc.’s proposed
public offering, joined Intensity Therapeutics, Inc.’s request for acceleration of the effective date of the above-referenced Registration
Statement for February 8, 2023, at 4:30 p.m. Eastern Time. Intensity Therapeutics, Inc. is no longer requesting that such Registration
Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,

THE
BENCHMARK COMPANY, LLC

As representative of the

several Underwriters

    By:
    /s/ Michael Jacobs

    Name:
    Michael Jacobs

    Title:
    MD/Head of ECM